Article
FDA Settlement With Amarin Permits Off-Label Drug Promotion
On March 8, the U.S. Food and Drug Administration and Amarin Pharma, Inc. entered into a settlement agreement resolving litigation brought by Amarin against the FDA related to Amarin's off-label promotion of Vascepa®...
Day Pitney LLP
